Cumulative inflammatory load is associated with short leukocyte telomere length in the health, aging and body composition study

PLoS ONE

Volumn 6, Issue 5, 2011, Pages

  O'Donovan, Aoife ^a,b   Pantell, Matthew S ^a   Puterman, Eli ^a   Dhabhar, Firdaus S ^c   Blackburn, Elizabeth H ^d   Yaffe, Kristine ^a,b,d   Cawthon, Richard M ^e   Opresko, Patricia L ^f   Hsueh, Wen Chi ^d   Satterfield, Suzanne ^g   Newman, Anne B ^h   Ayonayon, Hilsa N ^d   Rubin, Susan M ^d   Harris, Tamara B ⁱ   Epel, Elissa S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c STANFORD UNIVERSITY   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF PITTSBURGH   (United States)

^g UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^h UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

ⁱ NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; BIOLOGICAL MARKER;

ACUTE PHASE RESPONSE; ADULT; AGED; AGING; ARTICLE; BODY COMPOSITION; CHROMOSOME SIZE; CONTROLLED STUDY; DISEASE MARKER; FEMALE; HEALTH STATUS; HUMAN; INFLAMMATION; MALE; POPULATION RISK; PROTEIN BLOOD LEVEL; RISK FACTOR; TELOMERE; LEUKOCYTE; PATHOLOGY; RISK; ULTRASTRUCTURE;

AGED; AGING; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; HUMANS; INFLAMMATION; INTERLEUKIN-6; LEUKOCYTES; ODDS RATIO; TELOMERE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79955942152     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0019687     Document Type: Article

References (52)

1. Willeit P, Willeit J, Mayr A, Weger S, Oberhollenzer F, et al. (2010) Telomere length and risk of incident cancer and cancer mortality. JAMA 304: 69-75.
2. Fitzpatrick AL, Kronmal RA, Gardner JP, Psaty BM, Jenny NS, et al. (2007) Leukocyte telomere length and cardiovascular disease in the Cardiovascular Health Study. Am J Epidemiol 165: 14-21.
3. Farzaneh-Far R, Cawthon RM, Na B, Browner WS, Schiller NB, et al. (2008) Prognostic value of leukocyte telomere length in patients with stable coronary artery disease: data from the Heart and Soul Study. Arterioscler Thromb Vasc Biol 28: 1379-1384.
4. Epel ES, Merkin SS, Cawthon R, Blackburn EH, Adler NE, et al. (2009) The rate of leukocyte telomere shortening predicts mortality from cardiovascular disease in elderly men. Aging 1: 81-88.
5. Carrero JJ, Stenvinkel P, Fellstrom B, Qureshi AR, Lamb K, et al. (2008) Telomere attrition is associated with inflammation, low fetuin-A levels and high mortality in prevalent haemodialysis patients. J Int Med 263: 302-312.
6. Cawthon RM, Smith KR, O'Brien E, Sivatchenko A, Kerber RA, (2003) Association between telomere length in blood and mortality in people aged 60 years or older. Lancet 361: 393-395.
7. Njajou OT, Hsueh WC, Blackburn EH, Newman AB, Wu SH, et al. (2009) Association between telomere length, specific causes of death, and years of healthy life in health, aging, and body composition, a population-based cohort study. J Gerontol A Biol Sci Med Sci 64: 860-864.
8. Blackburn EH, (1991) Structure and function of telomeres. Nature 350: 569-573.
9. Blackburn EH, (2001) Switching and Signaling at the Telomere. Cell 106: 661-673.
10. Sahin E, Colla S, Liesa M, Moslehi J, Muller FL, et al. (2011) Telomere dysfunction induces metabolic and mitochondrial compromise. Nature 470: 359-365.
11. Jaskelioff M, Muller FL, Paik JH, Thomas E, Jiang S, et al. (2011) Telomerase reactivation reverses tissue degeneration in aged telomerase-deficient mice. Nature 469: 102-106.
12. Chung HY, Kim HJ, Kim KW, Choi JS, Yu BP, (2002) Molecular inflammation hypothesis of aging based on the anti-aging mechanism of calorie restriction. Microsc Res Tech 59: 264-272.
13. Chung HY, Kim HJ, Kim JW, Yu BP, (2001) The Inflammation Hypothesis of Aging: molecular modulation by calorie restriction. Ann NY Acad Sci 928: 327-335.
14. Kinouchi Y, Hiwatashi N, Chida M, Nagashima F, Takagi S, et al. (1998) Telomere shortening in the colonic mucosa of patients with ulcerative colitis. J Gastroenterol 33: 343-348.
15. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM, (2001) C-reactive protein, interleukin 6, and risk of developing type-2 diabetes mellitus. JAMA 286: 327-334.
16. Libby P, Ridker PM, Maseri A, (2002) Inflammation and atherosclerosis. Circulation 105: 1135-1143.
17. Wyss-Coray T, (2006) Inflammation in Alzheimer disease: driving force, bystander or beneficial response? Nat Med 12: 1005-1015.
18. Moss SF, Blaser MJ, (2005) Mechanisms of disease: inflammation and the origins of cancer. Nat Clin Prac Oncol 2: 90-97.
19. Harris TB, Ferrucci L, Tracy RP, Corti MC, Wacholder S, et al. (1999) Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med 106: 506-512.
20. Volpato S, Guralnik JM, Ferrucci L, Balfour J, Chaves P, et al. (2001) Cardiovascular disease, interleukin-6, and risk of mortality in older women: The Women's Health and Aging Study. Circulation 103: 947-953.
21. Slattery ML, Curtin K, Baumgartner R, Sweeney C, Byers T, et al. (2007) IL6, aspirin, nonsteroidal anti-inflammatory drugs, and breast cancer risk in women living in the southwestern United States. Cancer Epidemiol Biomarkers Prev 16: 747-755.
22. Aviv A, (2004) Telomeres and human aging: facts and fibs. Sci Aging Knowledge Environ 2004: pe43.
23. Jaiswal M, LaRusso NF, Burgart LJ, Gores GJ, (2000) Inflammatory cytokines induce DNA damage and inhibit DNA repair in cholangiocarcinoma cells by a nitric oxide-dependent mechanism. Cancer Res 60: 184-190.
24. Xu D, Erickson S, Szeps M, Gruber A, Sangfelt O, et al. (2000) Interferon alpha down-regulates telomerase reverse transcriptase and telomerase activity in human malignant and nonmalignant hematopoietic cells. Blood 96: 4313-4318.
25. Parish ST, Wu JE, Effros RB, (2009) Modulation of T lymphocyte replicative senescence via TNF-{alpha} inhibition: role of caspase-3. J Immunol 182: 4237-4243.
26. Akiyama M, Yamada O, Hideshima T, Yanagisawa T, Yokoi K, et al. (2004) TNF[alpha] induces rapid activation and nuclear translocation of telomerase in human lymphocytes. Biochem Biophys Res Commun 316: 528-532.
27. Greider CW, Blackburn EH, (1989) A telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis. Nature 337: 331-337.
28. Rodier F, Coppe JP, Patil CK, Hoeijmakers WA, Munoz DP, et al. (2009) Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion. Nat Cell Biol 11: 973-979.
29. Krtolica A, Parrinello S, Lockett S, Desprez PY, Campisi J, (2001) Senescent fibroblasts promote epithelial cell growth and tumorigenesis: a link between cancer and aging. Proc Natl Acad Sci U S A 98: 12072-12077.
30. Aikata H, Takaishi H, Kawakami Y, Takahashi S, Kitamoto M, et al. (2000) Telomere reduction in human liver tissues with age and chronic inflammation. Exp Cell Res 256: 578-582.
31. Steer SE, Williams FM, Kato B, Gardner JP, Norman PJ, et al. (2007) Reduced telomere length in rheumatoid arthritis is independent of disease activity and duration. Ann Rheum Dis 66: 476-480.
32. Houben JM, Mercken EM, Ketelslegers HB, Bast A, Wouters EF, et al. (2009) Telomere shortening in chronic obstructive pulmonary disease. Respir Med 103: 230-236.
33. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO 3rd, et al. (2003) Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107: 499-511.
34. Castell JV, Gomez-Lechon MJ, David M, Andus T, Geiger T, et al. (1989) Interleukin-6 is the major regulator of acute phase protein synthesis in adult human hepatocytes. FEBS Lett 242: 237-239.
35. Castell JV, Gomez-Lechon MJ, David M, Hirano T, Kishimoto T, et al. (1988) Recombinant human interleukin-6 (IL-6/BSF-2/HSF) regulates the synthesis of acute phase proteins in human hepatocytes. FEBS Lett 232: 347-350.
36. Weinhold B, Bader A, Poli V, Ruther U, (1997) Interleukin-6 is necessary, but not sufficient, for induction of the humanC-reactive protein gene in vivo. Biochem J 325 (Pt 3): 617-621.
37. Calabro P, Willerson JT, Yeh ET, (2003) Inflammatory cytokines stimulated C-reactive protein production by human coronary artery smooth muscle cells. Circulation 108: 1930-1932.
38. Coppe JP, Patil CK, Rodier F, Sun Y, Munoz DP, et al. (2008) Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol 6: 2853-2868.
39. Lin MT, Juan CY, Chang KJ, Chen WJ, Kuo ML, (2001) IL-6 inhibits apoptosis and retains oxidative DNA lesions in human gastric cancer AGS cells through up-regulation of anti-apoptotic gene mcl-1. Carcinogenesis 22: 1947-1953.
40. Mangan DF, Wahl SM, (1991) Differential regulation of human monocyte programmed cell death (apoptosis) by chemotactic factors and pro-inflammatory cytokines. J Immunol 147: 3408-3412.
41. Elliott P, Chambers JC, Zhang W, Clarke R, Hopewell JC, et al. (2009) Genetic Loci associated with C-reactive protein levels and risk of coronary heart disease. JAMA 302: 37-48.
42. Kritchevsky SB, Cesari M, Pahor M, (2005) Inflammatory markers and cardiovascular health in older adults. Cardiovasc Res 66: 265-275.
43. Cesari M, Penninx BW, Newman AB, Kritchevsky SB, Nicklas BJ, et al. (2003) Inflammatory markers and cardiovascular disease: The Health, Aging and Body Composition [Health ABC] Study. Am J Cardiol 92: 522-528.
44. Nishida H, Horio T, Suzuki Y, Iwashima Y, Tokudome T, et al. (2011) Interleukin-6 as an independent predictor of future cardiovascular events in high-risk Japanese patients: comparison with C-reactive protein. Cytokine 53: 342-346.
45. Aviv A, (2009) Commentary: Raising the bar on telomere epidemiology. Int J Epidemiol 38: 1735-1736.
46. Aviv A, (2008) The epidemiology of human telomeres: faults and promises. J Gerontol A Biol Sci Med Sci 63: 979-983.
47. Cawthon RM, (2002) Telomere measurement by quantitative PCR. Nucl Acids Res 30: e47.
48. Njajou OT, Blackburn EH, Pawlikowska L, Mangino M, Damcott CM, et al. (2010) A common variant in the telomerase RNA component is associated with short telomere length. PLoS ONE 5: e13048.
49. Cawthon RM, (2009) Telomere length measurement by a novel monochrome multiplex quantitative PCR method. Nucleic Acids Res 37: e21.
50. Steyerberg EW, Eijkemans MJ, Harrell FE Jr, Habbema JD, (2001) Prognostic modeling with logistic regression analysis: in search of a sensible strategy in small data sets. Med Decis Making 21: 45-56.
51. Sun GW, Shook TL, Kay GL, (1996) Inappropriate use of bivariable analysis to screen risk factors for use in multivariable analysis. J Clin Epidemiol 49: 907-916.
52. Pahor M, Chrischilles EA, Guralnik JM, Brown SL, Wallace RB, et al. (1994) Drug data coding and analysis in epidemiologic studies. Eur J Epidemiol 10: 405-411.